Intervention

perphenazine

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 3 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials3

Recruiting0

Common conditions1

Lead sponsors shown3

Clinical trials

3 shown

Twelve Month Study Comparing Paliperidone Palmitate and Select Oral Antipsychotics in Adults With Schizophrenia Who Have Been Recently Discharged From an Inpatient Psychiatric HospitalNCT01193166 · 2010-08-01

WITHDRAWN

15 Month Study for Adults Who Have Been Diagnosed With Schizophrenia and IncarceratedNCT01157351 · 2010-05-01

COMPLETED

CATIE- Schizophrenia TrialNCT00014001 · 2000-12-01

COMPLETED

Common conditions

Schizophrenia3

Leading sponsors

Janssen Scientific Affairs, LLC 1 National Institute of Mental Health (NIMH) 1 Ortho-McNeil Janssen Scientific Affairs, LLC 1

Trial status mix

COMPLETED2

WITHDRAWN1

Phase mix

PHASE43

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.